TABLE 7.
A. Absolute FBG | ||||||||
---|---|---|---|---|---|---|---|---|
Time point | CHD (5% fat) | HFD (42% fat) | ||||||
H2 | CVg | H2 | CVg | |||||
♀ | ♂ | ♀ | ♂ | ♀ | ♂ | ♀ | ♂ | |
Initial | 0.56 | 0.59 | 0.16 | 0.18 | 0.56 | 0.59 | 0.16 | 0.18 |
Pre‐treatment | 0.39 | 0.63 | 0.13 | 0.23 | 0.60 | 0.64 | 0.16 | 0.23 |
Post‐treatment | 0.80 | 0.43 | 0.26 | 0.16 | 0.50 | 0.73 | 0.15 | 0.28 |
B. % FBG | ||||||||
---|---|---|---|---|---|---|---|---|
Phenotype | CHD (5% fat) | HFD (42% fat) | ||||||
H2 | CVg | H2 | CVg | |||||
♀ | ♂ | ♀ | ♂ | ♀ | ♂ | ♀ | ♂ | |
% FBG 0–12 | 0.15 | 0.10 | −1.3 | −1.8 | 0.34 | 0.51 | 2.51 | 3.53 |
% FBG 12–18 | 0.47 | 0.43 | −2.9 | −3.8 | 0.46 | 0.63 | 3.43 | −3.09 |